Big news today from Venus Remedies, as the company confirmed receiving the final Rs 11 crore milestone from Cipla for its novel AMR-focused anti-infective. This marks the completion of all commercial milestones agreed under their 2019 deal...
Trivitron Healthcare and ResoHealth have established a joint venture called Trivitron Digital.AI (TDAI), which is a cutting-edge digital health initiative designed to address the existing adoption gaps on a large scale
India is exploring options to enhance the World Health Organisation (WHO) global benchmarking standards for medicines, aimed at standardizing and reinforcing the drug regulatory system for the safety, quality, and effectiveness of medications
Merck Animal Health, referred to as MSD Animal Health outside the U.S. and Canada, a branch of Merck & Co., Inc., Rahway, New Jersey, USA, revealed that the US Food and Drug Administration (FDA) has provided conditional approval for Exzolt Cattle-CA1
Sanofi has completed the acquisition of Vicebio Ltd, and this will make it stronger in the vaccine portfolio and prove its role as an innovative biopharma leader. The acquisition combines an exciting early-stage combination vaccine against...
AstraZeneca’s baxdrostat has taken a major step forward today as the US FDA accepted its New Drug Application (NDA) for Priority Review. The drug is aimed at adults with hard-to-control hypertension who need added help even after multiple blood...
Infertility, historically regarded as a personal challenge and costly medical issue, is now prominently featured on the global public-health agenda
Glenmark Pharmaceuticals has gained clear momentum in its U.S. pipeline after the USFDA completed a pre?approval inspection of its formulations plant in Chhatrapati Sambhajinagar. The inspection revealed zero 483 observations that reflects...
Piramal Pharma Solutions announced today that it has completed its journey to global nitrosamine compliance, marking a major step in strengthening patient safety and meeting evolving international expectations for nitrosamine impurities in...
The Sun Pharmaceutical Industries has secured approval from the U.S. Food and Drug Administration (FDA) for an expanded label for its immunotherapy drug UNLOXCYT (cosibelimab ipdl). The updated label authorizes UNLOXCYT for use in adults with...